These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
406 related items for PubMed ID: 1662512
1. A novel rat hepatic clofibrate-inducible cytochrome P450 that is not a lauric acid hydroxylase. Swinney DC, Webb AS, Freedman R. Biochem Pharmacol; 1991 Nov 27; 42(12):2341-9. PubMed ID: 1662512 [Abstract] [Full Text] [Related]
2. Involvement of cytochrome P450 2E1 in the (omega-1)-hydroxylation of oleic acid in human and rat liver microsomes. Adas F, Berthou F, Picart D, Lozac'h P, Beaugé F, Amet Y. J Lipid Res; 1998 Jun 27; 39(6):1210-9. PubMed ID: 9643352 [Abstract] [Full Text] [Related]
3. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid. Orton TC, Parker GL. Drug Metab Dispos; 1982 Jun 27; 10(2):110-5. PubMed ID: 6124394 [Abstract] [Full Text] [Related]
4. Leukotriene B4 omega-hydroxylase in rat liver microsomes: identification as a cytochrome P-450 that catalyzes prostaglandin A1 omega-hydroxylation, and participation of cytochrome b5. Sumimoto H, Kusunose E, Gotoh Y, Kusunose M, Minakami S. J Biochem; 1990 Aug 27; 108(2):215-21. PubMed ID: 2172223 [Abstract] [Full Text] [Related]
5. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation. Sharma RK, Lake BG, Makowski R, Bradshaw T, Earnshaw D, Dale JW, Gibson GG. Eur J Biochem; 1989 Sep 01; 184(1):69-78. PubMed ID: 2776771 [Abstract] [Full Text] [Related]
7. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds. Dirven HA, van den Broek PH, Peters JG, Noordhoek J, Jongeneelen FJ. Biochem Pharmacol; 1992 Jun 23; 43(12):2621-9. PubMed ID: 1632818 [Abstract] [Full Text] [Related]
10. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment. Boucher JL, Delaforge M, Salaün JP, Pinot F, Durst F, Pflieger P, Mioskowski C. Drug Metab Dispos; 1996 Apr 23; 24(4):462-8. PubMed ID: 8801062 [Abstract] [Full Text] [Related]
11. Regiospecificity in the hydroxylation of lauric acid by rainbow trout hepatic cytochrome P450 isozymes. Miranda CL, Wang JL, Henderson MC, Williams DE, Buhler DR. Biochem Biophys Res Commun; 1990 Sep 14; 171(2):537-42. PubMed ID: 2403346 [Abstract] [Full Text] [Related]
12. Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acid. Bains SK, Gardiner SM, Mannweiler K, Gillett D, Gibson GG. Biochem Pharmacol; 1985 Sep 15; 34(18):3221-9. PubMed ID: 3929789 [Abstract] [Full Text] [Related]
13. Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. Jin R, Koop DR, Raucy JL, Lasker JM. Arch Biochem Biophys; 1998 Nov 01; 359(1):89-98. PubMed ID: 9799565 [Abstract] [Full Text] [Related]
14. Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A. Adas F, Berthou F, Salaün JP, Dréano Y, Amet Y. Toxicol Lett; 1999 Oct 29; 110(1-2):43-55. PubMed ID: 10593594 [Abstract] [Full Text] [Related]
19. Characterization of human neutrophil leukotriene B4 omega-hydroxylase as a system involving a unique cytochrome P-450 and NADPH-cytochrome P-450 reductase. Sumimoto J, Takeshige K, Minakami S. Eur J Biochem; 1988 Mar 01; 172(2):315-24. PubMed ID: 3127205 [Abstract] [Full Text] [Related]